Skip to main content
. 2016 Oct 18;7(46):74569–74581. doi: 10.18632/oncotarget.12740

Table 1. Patient characteristics.

Demographics Controls (N=17) IPF (N=45) p value
Age (years) 48.2 ± 3.2 65.4 ± 1.8 <10−3
Gender
male
female
13
4
37
8
0.721
Smoking status
non smoker
ex smoker
smoker
2
3
9
16
24
2
<10−3
PY 36.0 ± 5.7 39.1 ± 7.1 0.764
Lung Function
FEV1% 92.7 ± 6.0 73.7 ± 3.1 0.009
FVC% 94.0 ± 5.4 71.6 ± 3.3 0.003
FEV1%/FVC% 79.7 ± 2.0 79.5 ± 1.2 0.938
TLC% 101.6 ± 7.7 67.6 ± 2.5 <10−3
DLco% 79.2 ± 5.5 43.4 ± 2.3 <10−3
KCO% 103.6 ± 8.1 77.5 ± 3.2 0.014
BAL cell count
Macrophages % 69 ± 8 73 ± 3 0.83
Lymphocytes % 24.3 ± 7.6 14.1 ± 2.7 0.17
Neutrophils % 3.7 ± 1.4 6.8 ± 1 0.12
Eosinophils % 0.8 ± 0.4 3.2 ± 0.6 0.04

Values are the means ± SEM. PY=pack years for ex and current smokers; FEV1= Forced expiratory volume in 1 second; FVC= Forced Vital Capacity; TLC= Total Lung Capacity; DLco= Transfer factor of the Lung for Carbon Monoxide; KCO= transfer coefficient.